Ethical Issues in HIV/AIDS and Substance Abuse Research
艾滋病毒/艾滋病和药物滥用研究中的伦理问题
基本信息
- 批准号:7266217
- 负责人:
- 金额:$ 17.09万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-07-01 至 2009-06-30
- 项目状态:已结题
- 来源:
- 关键词:3 year oldAIDS Treatment ResearchAIDS preventionAIDS/HIV problemAcademiaAcademic Medical CentersAccountingAcquired Immunodeficiency SyndromeAddressAdministratorAdolescentAdultAffectAfrican AmericanAgeAmericanAnatomyAnimal WelfareAnti-Retroviral AgentsAppendixAppointmentAreaAsthmaAwardAwarenessBasic ScienceBedsBehaviorBiochemistryBioethicsBiologicalBiological SciencesBudgetsCampingCaringCase StudyCause of DeathCenters for Disease Control and Prevention (U.S.)ChildChurchClassClinicClinicalClinical Ethics CommitteesClinical MedicineClinical ResearchClinical TrialsCollaborationsCommunitiesCommunity HealthCommunity Mental Health CentersCommunity OutreachCommunity WorkersComputersConditionCountryCrack CocaineCritiquesDataDecision MakingDevelopmentDisadvantagedDiscipline of obstetricsDiscriminationDiseaseDoctor of MedicineDoctor of PhilosophyDropsDrug abuseDrug usageEducationEducational CurriculumEducational workshopEmployeeEmployee StrikesEnrollmentEnvironmentEpidemicEquipmentEthical IssuesEthicistsEthicsExposure toFacultyFemaleFoundationsFundingFurnitureFutureGenderGeneral HospitalsGeneral PopulationGoalsGovernmentGrantGrowthGynecologyHIVHIV InfectionsHIV SeropositivityHIV vaccineHealth OccupationsHealth PersonnelHealth ProfessionalHealth PromotionHealth ServicesHealth Services ResearchHealthcareHeterosexualsHispanicsHome environmentHospital EthicsHospitalsHuman ResourcesHuman Subject ResearchHuman immunodeficiency virus testHumanitiesIncidenceIndividualInfectionInjection of therapeutic agentInstitutionInsurance CoverageIntentionJournalsLaboratoriesLeadLeadershipLearningLeftLettersLifeMalignant NeoplasmsMaternal-Fetal TransmissionMedicalMedical ResearchMedical StudentsMedical SurveillanceMedicineMicrobiologyMinorityMinority GroupsMolecular BiologyMothersNational Institute of Drug AbuseNeurosciencesNumbersNursing FacultyOccupationsOffice for Human Research ProtectionsPamphletsParticipantPatientsPediatricsPersonal SatisfactionPersonsPharmaceutical PreparationsPharmacologyPhysiciansPhysiologyPlacementPneumoniaPopulationPositioning AttributePregnancyPreparationPreventionPreventivePrincipal InvestigatorProceduresProfessional RoleProphylactic treatmentProtease InhibitorProviderPublished CommentQualifyingRateReadingRecording of previous eventsRegulationRelative (related person)ReportingReproductionResearchResearch EthicsResearch Ethics CommitteesResearch InfrastructureResearch PersonnelResearch TrainingRiskRisk FactorsRoleRotationRouteScheduleScholarshipScienceSeriesServicesSocietiesSoutheastern United StatesSpecific qualifier valueSpecificityStrategic PlanningStudentsSubstance abuse problemSuggestionSurveysSyphilisTechnologyTennesseeTestingThinkingTimeTitleTodayTrainingTraining ProgramsTraining SupportTravelTropical DiseaseUnderrepresented MinorityUnited StatesUnited States Food and Drug AdministrationUnited States National Institutes of HealthUnsafe SexUpdateVaccinationVaccine Clinical TrialVaccinesVulnerable PopulationsWomanWorkWritingagedbasecareercase-basedcollegedaydesignexperiencefallsfetalhealth care service organizationhealth disparityindexinginstrumentinterestintimate behaviormalemedical schoolsmembermenmen who have sex with menmetropolitanminority healthminority subjectsoutreach programpandemic diseasepreventprofessorprogramsrole modelsexsizesuccesssymposiumtransmission processtrendvolunteer
项目摘要
DESCRIPTION (provided by applicant): The current worldwide HIV/AIDS pandemic is having a devastating impact on African American and Hispanic populations in the United States. Recent surveillance data available from CDC indicate that 50% of new HIV infections occur in the African American community, which includes only 12% of the U.S. population. Hispanics, also representing 12% of the population account for 19% of new HIV cases. As much as one third of the HIV/AIDS in the African American community is associated with substance abuse, particularly injection drug use. Once infected, members of the minority community are less likely to receive timely care and are more apt to die sooner of AIDS associated disease. Given the horrific impact of HIV/AIDS on the African American community, one would assume that African Americans would be at the forefront of research efforts designed to develop better and cheaper treatments for AIDS and effective preventive vaccines. Unfortunately, the legacy of the Tuskegee Syphilis Trials lives on. The goal of this proposal is to increase understanding of the ethical issues surrounding the prevention and treatment of HIV/AIDS and substance abuse in minority communities and to better prepare researchers and other professionals to engage in ethically designed and implemented research of special significance to the minority community. The core of the program will be to offer on an annual basis: 1) a 2-day workshop "Seeing Beyond the Barriers: Minority Participation in HIV/AIDS and Substance Abuse Research" for persons involved in clinical research and ethical oversight of research involving HIV/AIDS and substance abuse. Participants may include researchers; physicians, IRB and CAB members and Community-based organization care providers. The course will offer a case-study approach to ethical issues in HIV/AIDS and substance abuse with class leadership provided by affected individuals, community leaders and professionals involved in these issues, and 2) a month long clinical elective "Clinical and Research Ethics: Issues in HIV/AIDS and Substance Abuse" for junior and senior medical and other students that will offer expertise in clinical and research ethics with emphasis on ethical issues relating to HIV/AIDS and substance abuse. The course will combine didactic presentations and case-study discussions with field experiences allowing students to interact with clinical researchers and community outreach leaders as they confront the ethical issues inherent in the practice of their professions.
描述(由申请人提供):当前全球范围内的艾滋病毒/艾滋病流行正在对美国的非裔美国人和西班牙裔人口产生毁灭性影响。 CDC 最近提供的监测数据表明,50% 的新艾滋病毒感染发生在非裔美国人社区,而该社区仅占美国人口的 12%。西班牙裔也占人口的 12%,占新艾滋病毒病例的 19%。非裔美国人社区中多达三分之一的艾滋病毒/艾滋病与药物滥用,特别是注射吸毒有关。一旦被感染,少数族裔社区的成员就不太可能得到及时的护理,并且更容易死于艾滋病相关疾病。鉴于艾滋病毒/艾滋病对非裔美国人社区的可怕影响,人们会认为非裔美国人将处于研究工作的最前沿,这些研究工作旨在开发更好、更便宜的艾滋病治疗方法和有效的预防性疫苗。不幸的是,塔斯基吉梅毒试验的遗产仍然存在。该提案的目标是增进对少数群体社区预防和治疗艾滋病毒/艾滋病和药物滥用的伦理问题的了解,并更好地准备研究人员和其他专业人员从事符合伦理的设计和实施对少数群体有特殊意义的研究社区。该计划的核心是每年提供:1)为期 2 天的研讨会“超越障碍:少数人参与艾滋病毒/艾滋病和药物滥用研究”,对象为参与临床研究和涉及以下研究的伦理监督的人员艾滋病毒/艾滋病和药物滥用。参与者可能包括研究人员;医生、IRB 和 CAB 成员以及社区组织护理提供者。该课程将提供有关艾滋病毒/艾滋病和药物滥用的伦理问题的案例研究方法,由受影响的个人、社区领袖和涉及这些问题的专业人士提供班级领导,以及 2) 为期一个月的临床选修课“临床和研究伦理: “艾滋病毒/艾滋病和药物滥用问题”面向初级和高级医学生和其他学生,将提供临床和研究伦理方面的专业知识,重点是与艾滋病毒/艾滋病和药物滥用有关的伦理问题。该课程将教学演示和案例研究讨论与现场经验相结合,使学生能够在临床研究人员和社区外展领导者面临其专业实践中固有的道德问题时与他们互动。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LINDA D SANDER其他文献
LINDA D SANDER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LINDA D SANDER', 18)}}的其他基金
Ethical Issues in HIV/AIDS and Substance Abuse Research
艾滋病毒/艾滋病和药物滥用研究中的伦理问题
- 批准号:
7076960 - 财政年份:2005
- 资助金额:
$ 17.09万 - 项目类别:
Ethical Issues in HIV/AIDS and Substance Abuse Research
艾滋病毒/艾滋病和药物滥用研究中的伦理问题
- 批准号:
6874654 - 财政年份:2005
- 资助金额:
$ 17.09万 - 项目类别:
FEEDING AND GI PEPTIDE EFFECT ON HYPOTHALAMIC/PITUITARY/ADRENAL AXIS
进食和胃肠肽对下丘脑/垂体/肾上腺轴的影响
- 批准号:
6485258 - 财政年份:2001
- 资助金额:
$ 17.09万 - 项目类别:
FEEDING AND GI PEPTIDE EFFECT ON HYPOTHALAMIC/PITUITARY/ADRENAL AXIS
进食和胃肠肽对下丘脑/垂体/肾上腺轴的影响
- 批准号:
6349106 - 财政年份:2000
- 资助金额:
$ 17.09万 - 项目类别:
INCREASING PARTICIPATION OF MINORITY RESEARCHERS IN ETH
增加少数族裔研究人员对 ETH 的参与
- 批准号:
6372857 - 财政年份:2000
- 资助金额:
$ 17.09万 - 项目类别:
INCREASING PARTICIPATION OF MINORITY RESEARCHERS IN ETH
增加少数族裔研究人员对 ETH 的参与
- 批准号:
6538126 - 财政年份:2000
- 资助金额:
$ 17.09万 - 项目类别:
FEEDING AND GI PEPTIDE EFFECT ON HYPOTHALAMIC/PITUITARY/ADRENAL AXIS
进食和胃肠肽对下丘脑/垂体/肾上腺轴的影响
- 批准号:
6204081 - 财政年份:1999
- 资助金额:
$ 17.09万 - 项目类别:
FEEDING AND GI PEPTIDE EFFECT ON HYPOTHALAMIC/PITUITARY/ADRENAL AXIS
进食和胃肠肽对下丘脑/垂体/肾上腺轴的影响
- 批准号:
6107045 - 财政年份:1998
- 资助金额:
$ 17.09万 - 项目类别:
FEEDING AND GI PEPTIDE EFFECT ON HYPOTHALAMIC/PITUITARY/ADRENAL AXIS
进食和胃肠肽对下丘脑/垂体/肾上腺轴的影响
- 批准号:
6239932 - 财政年份:1997
- 资助金额:
$ 17.09万 - 项目类别:
FEEDING AND GI PEPTIDE EFFECT ON HYPOTHALAMIC/PITUITARY/ADRENAL AXIS
进食和胃肠肽对下丘脑/垂体/肾上腺轴的影响
- 批准号:
5211548 - 财政年份:
- 资助金额:
$ 17.09万 - 项目类别:
相似国自然基金
基于艾滋病抗病毒治疗的多尺度动力学模型研究
- 批准号:82073673
- 批准年份:2020
- 资助金额:56 万元
- 项目类别:面上项目
基于双向队列的中医药治疗艾滋病疗效评价联合模型构建研究
- 批准号:81873187
- 批准年份:2018
- 资助金额:56.0 万元
- 项目类别:面上项目
艾滋病感知歧视的内隐效应、慢性压力对临床治疗效果影响的心理-生理机制研究
- 批准号:81803293
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
针对中国艾滋病病人的特异性治疗抗体的开发及作用机理的研究
- 批准号:31771008
- 批准年份:2017
- 资助金额:60.0 万元
- 项目类别:面上项目
基于APP的艾滋病治疗依从性优化策略及机制研究
- 批准号:81602943
- 批准年份:2016
- 资助金额:17.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Implementing SafeCare Kenya to Reduce Noncommunicable Disease Burden: Building Community Health Workers' Capacity to Support Parents with Young Children
实施 SafeCare Kenya 以减少非传染性疾病负担:建设社区卫生工作者支持有幼儿的父母的能力
- 批准号:
10672785 - 财政年份:2023
- 资助金额:
$ 17.09万 - 项目类别:
IAS 2023, the 12th IAS Conference on HIV Science, Brisbane, Australia, and virtually, 23-26 July 2023
IAS 2023,第 12 届 IAS HIV 科学会议,澳大利亚布里斯班,虚拟会议,2023 年 7 月 23-26 日
- 批准号:
10696505 - 财政年份:2023
- 资助金额:
$ 17.09万 - 项目类别:
KEMRI-PHRD UG1 CASCADE NETWORK UNIT: CERVICAL CANCER PREVENTION FOR WOMEN LIVING WITH HIV RESEARCH
KEMRI-PHRD UG1 级联网络单元:艾滋病毒感染女性的宫颈癌预防研究
- 批准号:
10763054 - 财政年份:2023
- 资助金额:
$ 17.09万 - 项目类别:
XVIR-110 an ultra-long-acting INSTI for HIV pre-exposure prophylaxis in IND-enabling studies
XVIR-110 是一种超长效 INSTI,用于 IND 支持研究中的 HIV 暴露前预防
- 批准号:
10764186 - 财政年份:2023
- 资助金额:
$ 17.09万 - 项目类别: